Sort   by:  
 Page size 
UnknownAllogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
Not available
S-EPMC4872017 | biostudies-literature
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219 | biostudies-literature
UnknownInhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
Not available
S-EPMC10597427 | biostudies-literature
UnknownCommon variation in PHACTR1 is associated with susceptibility to cervical artery dissection.
Not available
S-EPMC5824623 | biostudies-literature
UnknownEffect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9941969 | biostudies-literature
UnknownEffect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9857647 | biostudies-literature
UnknownEffect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9587497 | biostudies-literature
UnknownMetformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC12261116 | biostudies-literature
UnknownA user's guide to the encyclopedia of DNA elements (ENCODE).
Not available
S-EPMC3079585 | biostudies-literature
UnknownTime to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631 | biostudies-literature
Sort   by:  
 Page size